Amicus Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

Amicus Therapeutics (Nasdaq: FOLD), a global biotechnology company focused on rare diseases, has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference. Bradley Campbell, President and Chief Executive Officer, will deliver a presentation in San Francisco on Monday, January 13, 2025, at 3:00 p.m. PT.

The presentation will be accessible through a live audio webcast via the investors section of the Amicus Therapeutics corporate website. The company, dedicated to discovering, developing, and delivering novel medicines for rare diseases, maintains a commitment to advancing its pipeline of first- or best-in-class medicines.

News Market Reaction

-1.17%

1 alert

-1.17% News Effect

On the day this news was published, FOLD declined 1.17%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

PRINCETON, N.J., Jan. 02, 2025 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that Bradley Campbell, President and Chief Executive Officer, will present at the 43^rd Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Monday, January 13, 2025, at 3:00 p.m. PT.

A live audio webcast of the presentation can also be accessed via the investors section of the Amicus Therapeutics corporate website at https://ir.amicusrx.com/events-and-presentations.

About Amicus Therapeutics
Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, Amicus Therapeutics is committed to advancing and expanding a pipeline of cutting-edge, first- or best-in-class medicines for rare diseases. For more information please visit the company’s website at www.amicusrx.com, and follow on X and LinkedIn.

CONTACT:

Investors:
Amicus Therapeutics
Andrew Faughnan
Vice President, Investor Relations
afaughnan@amicusrx.com
(609) 662-3809

Media:
Amicus Therapeutics
Diana Moore
Head of Global Corporate Affairs and Communications
dmoore@amicusrx.com
(609) 662-5079

FOLD–G

FAQ

When is Amicus Therapeutics (FOLD) presenting at the J.P. Morgan Healthcare Conference 2025?

Amicus Therapeutics will present on Monday, January 13, 2025, at 3:00 p.m. PT in San Francisco.

How can investors access the FOLD presentation at the J.P. Morgan Healthcare Conference?

Investors can access the live audio webcast through the investors section of the Amicus Therapeutics corporate website at ir.amicusrx.com/events-and-presentations.

What is the main focus of Amicus Therapeutics (FOLD)?

Amicus Therapeutics is a global biotechnology company focused on discovering, developing, and delivering novel high-quality medicines for people living with rare diseases.

Who will represent FOLD at the 2025 J.P. Morgan Healthcare Conference?

Bradley Campbell, President and Chief Executive Officer of Amicus Therapeutics, will present at the conference.